A.I. Kryukov
Research Subjects
Research Interests
A.I. Kryukov has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Evgenii V. Garov
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute; Pirogov Russian National Research Medical University (Pirogov Medical University)
6 shared publications - Victoria N. Zelenkova
Sverzhevsky Research Clinical Institute of Otorhinolaryngology
5 shared publications - E. E. Zagorskaya
L.I. Sverzhevsky Research Clinical Institute of Otolaryngology
4 shared publications - E.E. Garova
Sverzhevsky Research Clinical Institute of Otorhinolaryngology
4 shared publications - Natalia L. Kunelskaya
Sverzhevsky Research Clinical Institute of Otorhinolaryngology
4 shared publications - Elena Isaakovna Zelikovich
Sverzhevsky Research Clinical Institute of Otorhinolaryngology
3 shared publications
Latest Publications
- 4 September 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (4)
Hormone therapy for stapedoplasty in patients with otosclerosis
Surgical treatment of hearing loss due to otosclerosis is characterized by high clinical efficacy and ensures achievement of an air-bone gap of ≤10 dB in 58—97% of patients. However, acute sensorineural hearing loss as a complication of stapedoplasty occurs in 0.2—0.95% of cases after the primary intervention, in 2.9% after revision stapedoplasty and in 4.8% with the obliterating otosclerosis. Intraoperative adverse factors arising during stapedoplasty play the leading role in the development of early cochleovestibular disorders. On the other hand, the use of glucocorticosteroids (GCS) in the surgical management of patients with otosclerosis remains a subject of debate, as the indications for their use, optimal routes of administration, and clinical efficacy still lack sufficient scientific justification. Objective. To determine the indications for and evaluate the efficacy of hormonal therapy methods in patients undergoing stapedoplasty for otosclerosis. Material and methods. Between 2020 and 2023, a total of 112 patients with otosclerosis were examined and surgically treated. Among them, 83 were women and 29 were men; the mean age of the patients was 44±10.5 years. The diagnosis was based on data from otomicroscopy, pure-tone audiometry, acoustic impedance audiometry, and computed tomography of the temporal bones, which served to confirm the condition and identify factors that could adversely affect stapedoplasty outcomes. Functional results were assessed using pure-tone audiometry at days 2 and 7, as well as at 3, 6, and 12 months postoperatively. Considering the features of the intraoperative course, the dynamics of air-bone gap closure, and the GCS therapy regimen applied, the patients were divided into three groups. Group 1 consisted of 45 patients who did not receive GCS therapy. Group 2 included 54 patients, subdivided into 2 subgroups: 22 subjects (Group 2a) received topical GCS therapy using bioabsorbable collagen sponges impregnated with the drug and inserted into the round window niche, and 32 subjects (Group 2b) received systemic GCS therapy. The latter was administered due to an adverse intraoperative course to prevent postoperative complications. Group 3 consisted of 13 patients in whom GCS were used both topically and systemically due to adverse intraoperative factors during stapedoplasty and a subsequent increase in bone conduction thresholds detected on day 2 after surgical treatment. Results. The key factors determining the need for GCS therapy were intraoperative features of the stapedoplasty procedure. In particular, intense tissue bleeding and a pronounced vestibular reaction during vestibulotomy (p≤0.001), as well as blood entering the vestibule and the “dry” vestibule phenomenon (p≤0.05), were significant. In addition, the development of cochleovestibular disorders in the postoperative period is associated not with individual factors, but with their combination. An analysis of the efficacy of topical and systemic dexamethasone in the early stages after stapedoplasty was done based on bone conduction threshold dynamics. In contrast to Group 2b, patients in Groups 1 and 2a showed no clinically significant increase in bone conduction thresholds or signs of cochleovestibular disorders. The results obtained in patients of Group 2a may be attributed to prolonged topical GCS exposure during the intraoperative period when using the developed technique. Despite the higher frequency of combined intraoperative complications in patients of Group 3, bone conduction thresholds remained stable in the postoperative period, which is associated with the use of combination GCS therapy. Conclusion. In patients with otosclerosis, glucocorticosteroid therapy is indicated for managing adverse intraoperative factors and elevated bone conduction thresholds after stapedoplasty. In cases of intraoperative adverse factors in the absence of cochleovestibular disorders in the postoperative period, the use of topical glucocorticosteroid therapy by placing a hemostatic sponge soaked in dexamethasone solution into the round window niche using the original technique is sufficient to achieve satisfactory functional outcomes. Combined topical and systemic glucocorticosteroid therapy is advisable for treating postoperative cochleovestibular disorders and preventing further progression of hearing loss.
- 4 September 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (4)
Hormone therapy for stapedoplasty in patients with otosclerosis
Surgical treatment of hearing loss due to otosclerosis is characterized by high clinical efficacy and ensures achievement of an air-bone gap of ≤10 dB in 58—97% of patients. However, acute sensorineural hearing loss as a complication of stapedoplasty occurs in 0.2—0.95% of cases after the primary intervention, in 2.9% after revision stapedoplasty and in 4.8% with the obliterating otosclerosis. Intraoperative adverse factors arising during stapedoplasty play the leading role in the development of early cochleovestibular disorders. On the other hand, the use of glucocorticosteroids (GCS) in the surgical management of patients with otosclerosis remains a subject of debate, as the indications for their use, optimal routes of administration, and clinical efficacy still lack sufficient scientific justification. Objective. To determine the indications for and evaluate the efficacy of hormonal therapy methods in patients undergoing stapedoplasty for otosclerosis. Material and methods. Between 2020 and 2023, a total of 112 patients with otosclerosis were examined and surgically treated. Among them, 83 were women and 29 were men; the mean age of the patients was 44±10.5 years. The diagnosis was based on data from otomicroscopy, pure-tone audiometry, acoustic impedance audiometry, and computed tomography of the temporal bones, which served to confirm the condition and identify factors that could adversely affect stapedoplasty outcomes. Functional results were assessed using pure-tone audiometry at days 2 and 7, as well as at 3, 6, and 12 months postoperatively. Considering the features of the intraoperative course, the dynamics of air-bone gap closure, and the GCS therapy regimen applied, the patients were divided into three groups. Group 1 consisted of 45 patients who did not receive GCS therapy. Group 2 included 54 patients, subdivided into 2 subgroups: 22 subjects (Group 2a) received topical GCS therapy using bioabsorbable collagen sponges impregnated with the drug and inserted into the round window niche, and 32 subjects (Group 2b) received systemic GCS therapy. The latter was administered due to an adverse intraoperative course to prevent postoperative complications. Group 3 consisted of 13 patients in whom GCS were used both topically and systemically due to adverse intraoperative factors during stapedoplasty and a subsequent increase in bone conduction thresholds detected on day 2 after surgical treatment. Results. The key factors determining the need for GCS therapy were intraoperative features of the stapedoplasty procedure. In particular, intense tissue bleeding and a pronounced vestibular reaction during vestibulotomy (p≤0.001), as well as blood entering the vestibule and the “dry” vestibule phenomenon (p≤0.05), were significant. In addition, the development of cochleovestibular disorders in the postoperative period is associated not with individual factors, but with their combination. An analysis of the efficacy of topical and systemic dexamethasone in the early stages after stapedoplasty was done based on bone conduction threshold dynamics. In contrast to Group 2b, patients in Groups 1 and 2a showed no clinically significant increase in bone conduction thresholds or signs of cochleovestibular disorders. The results obtained in patients of Group 2a may be attributed to prolonged topical GCS exposure during the intraoperative period when using the developed technique. Despite the higher frequency of combined intraoperative complications in patients of Group 3, bone conduction thresholds remained stable in the postoperative period, which is associated with the use of combination GCS therapy. Conclusion. In patients with otosclerosis, glucocorticosteroid therapy is indicated for managing adverse intraoperative factors and elevated bone conduction thresholds after stapedoplasty. In cases of intraoperative adverse factors in the absence of cochleovestibular disorders in the postoperative period, the use of topical glucocorticosteroid therapy by placing a hemostatic sponge soaked in dexamethasone solution into the round window niche using the original technique is sufficient to achieve satisfactory functional outcomes. Combined topical and systemic glucocorticosteroid therapy is advisable for treating postoperative cochleovestibular disorders and preventing further progression of hearing loss.
- 4 September 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (4)
Modern possibilities for the diagnosis of voice disorders using computer acoustic analysis of voice and artificial intelligence
Objective. The purpose of the review is to analyze modern approaches to the diagnosis of voice disorders using AI and acoustic analysis, as well as to evaluate their effectiveness and prospects for implementation in clinical practice. Research design. A review of domestic and foreign literature sources on the use of computer acoustic analysis and AI technologies in the diagnosis of diseases of the vocal apparatus is carried out. Material and methods. The material for the analysis was publications in scientific journals, the results of clinical trials, data on the use of specialized software systems (PRAAT, MDVP, LingWaves) and machine learning-based systems (SVM, CNN, RNN and their combinations). Data on diagnostic accuracy, interpretability of results, and applicability in real clinical practice were considered. Results. Acoustic analysis of the voice makes it possible to detect pathological changes in the early stages, before the appearance of pronounced symptoms. The PRAAT and MDVP programs have become the standard in assessing the spectral and temporal characteristics of a voice. The introduction of AI has significantly improved diagnostic accuracy (up to 95–97% in individual studies). Machine learning algorithms and deep neural networks automate diagnostics, allow you to identify hidden patterns and use data obtained even from mobile devices. However, there are still unresolved issues of database standardization, interpretability of models, and ethical and legal aspects of their implementation. Despite the high efficiency of technologies, their use requires the development of uniform standards, ensuring the transparency of algorithms and multidisciplinary interaction of specialists.
- 4 September 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (4)
Modern possibilities for the diagnosis of voice disorders using computer acoustic analysis of voice and artificial intelligence
Objective. The purpose of the review is to analyze modern approaches to the diagnosis of voice disorders using AI and acoustic analysis, as well as to evaluate their effectiveness and prospects for implementation in clinical practice. Research design. A review of domestic and foreign literature sources on the use of computer acoustic analysis and AI technologies in the diagnosis of diseases of the vocal apparatus is carried out. Material and methods. The material for the analysis was publications in scientific journals, the results of clinical trials, data on the use of specialized software systems (PRAAT, MDVP, LingWaves) and machine learning-based systems (SVM, CNN, RNN and their combinations). Data on diagnostic accuracy, interpretability of results, and applicability in real clinical practice were considered. Results. Acoustic analysis of the voice makes it possible to detect pathological changes in the early stages, before the appearance of pronounced symptoms. The PRAAT and MDVP programs have become the standard in assessing the spectral and temporal characteristics of a voice. The introduction of AI has significantly improved diagnostic accuracy (up to 95–97% in individual studies). Machine learning algorithms and deep neural networks automate diagnostics, allow you to identify hidden patterns and use data obtained even from mobile devices. However, there are still unresolved issues of database standardization, interpretability of models, and ethical and legal aspects of their implementation. Despite the high efficiency of technologies, their use requires the development of uniform standards, ensuring the transparency of algorithms and multidisciplinary interaction of specialists.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (3) , 100-106
Promising methods for sensorineural hearing loss treatment: Cellular technologies
This article presents a literature review on the molecular mechanisms of the inner ear damage and current approaches to restoring its cellular structures. The search for sources was carried out in the RSCI, Scopus, PubMed and Google Scholar databases. The advantages and limitations of various approaches to cochlear hair cell regeneration, as well as prospects for their development, are discussed. Particular attention is paid to discoveries in the field of gene therapy for inner ear diseases.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (3) , 100-106
Promising methods for sensorineural hearing loss treatment: Cellular technologies
This article presents a literature review on the molecular mechanisms of the inner ear damage and current approaches to restoring its cellular structures. The search for sources was carried out in the RSCI, Scopus, PubMed and Google Scholar databases. The advantages and limitations of various approaches to cochlear hair cell regeneration, as well as prospects for their development, are discussed. Particular attention is paid to discoveries in the field of gene therapy for inner ear diseases.
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 78-83
Promising methods of treatment of sensorineural hearing loss. Solving the issues of drug delivery
This literature review focuses on modern methods of drug delivery to the inner ear, which aim to enhance treatment effectiveness and reduce the risk of side effects. It examines systemic, transtympanic, and intracochlear routes of administration, along with their advantages and disadvantages. The review discusses new technologies such as hydrogels and nanoparticles that enable prolonged and targeted delivery of medications without the need for surgical intervention. Additionally, biophysical methods that allow non-invasive and highly precise drug delivery are presented.
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 78-83
Promising methods of treatment of sensorineural hearing loss. Solving the issues of drug delivery
This literature review focuses on modern methods of drug delivery to the inner ear, which aim to enhance treatment effectiveness and reduce the risk of side effects. It examines systemic, transtympanic, and intracochlear routes of administration, along with their advantages and disadvantages. The review discusses new technologies such as hydrogels and nanoparticles that enable prolonged and targeted delivery of medications without the need for surgical intervention. Additionally, biophysical methods that allow non-invasive and highly precise drug delivery are presented.
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 50-56
Prospects for the use of 3D bioprinting and tissue engineering technologies in clinical otorhinolaryngology (literature review)
The article provides an overview of data on the prevalence, conservative, and surgical treatment of chronic suppurative otitis media, which remains one of the most common and socially significant diseases of the otorhinolaryngological structures, accompanied by a high frequency of complications and persistent hearing loss. The evolution of treatment methods is traced, and special attention is given to the prospects for the use of tissue engineering constructs and tissue engineering in general. The possibilities of creating three-layer grafts are highlighted, taking into account the achievements of scientific and technological progress. It has been shown that classical methods of surgical correction of defects of the eardrum, including the use of autografts (temporal fascia, cartilage), do not always allow to achieve a sustainable anatomical and functional result, especially in large and persistent perforations. There is a tendency of active development of the direction of regenerative medicine and tissue engineering, allowing to create biocompatible grafts with specified properties, to introduce mesenchymal stem cells, as well as to use growth factors to stimulate reparative processes. The review analyzes data on the effectiveness of classical and innovative tympanoplasty methods, as well as the prospects for using 3D bioprinting, collagen matrices, and cellular technologies to restore the integrity of the eardrum. Special attention is paid to the results of clinical and experimental studies that demonstrate a significant increase in the frequency of successful closure of perforations when using tissue engineering constructs and growth factors compared to traditional methods. The article discusses unresolved issues related to the optimization of technologies, the standardization of protocols, and the need for further multicenter studies to widely implement innovative approaches in clinical practice.
- 12 May 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (2) , 50-56
Prospects for the use of 3D bioprinting and tissue engineering technologies in clinical otorhinolaryngology (literature review)
The article provides an overview of data on the prevalence, conservative, and surgical treatment of chronic suppurative otitis media, which remains one of the most common and socially significant diseases of the otorhinolaryngological structures, accompanied by a high frequency of complications and persistent hearing loss. The evolution of treatment methods is traced, and special attention is given to the prospects for the use of tissue engineering constructs and tissue engineering in general. The possibilities of creating three-layer grafts are highlighted, taking into account the achievements of scientific and technological progress. It has been shown that classical methods of surgical correction of defects of the eardrum, including the use of autografts (temporal fascia, cartilage), do not always allow to achieve a sustainable anatomical and functional result, especially in large and persistent perforations. There is a tendency of active development of the direction of regenerative medicine and tissue engineering, allowing to create biocompatible grafts with specified properties, to introduce mesenchymal stem cells, as well as to use growth factors to stimulate reparative processes. The review analyzes data on the effectiveness of classical and innovative tympanoplasty methods, as well as the prospects for using 3D bioprinting, collagen matrices, and cellular technologies to restore the integrity of the eardrum. Special attention is paid to the results of clinical and experimental studies that demonstrate a significant increase in the frequency of successful closure of perforations when using tissue engineering constructs and growth factors compared to traditional methods. The article discusses unresolved issues related to the optimization of technologies, the standardization of protocols, and the need for further multicenter studies to widely implement innovative approaches in clinical practice.
- 28 December 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (6) , 5-14
Features and results of surgical rehabilitation of hearing loss in osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a form of congenital osteoporosis. Depending on the type of OI, patients experience various types of hearing loss. Depending on the type and degree of hearing loss, various methods of hearing rehabilitation are used in this category of patients. Objective. To evaluate the features and results of surgical rehabilitation of hearing loss in patients with osteogenesis imperfecta. Material and methods. During the period from 2009 to 2022, 2221 primary stapedoplasty was performed in the department, of which 23 (1.04%) in 21 patients were performed in patients with OI. There were 14 women and 7 men. According to TPA, bilateral hearing loss was detected in 19 patients and unilateral in 2. Conductive hearing loss was observed in 9 cases and mixed — in 14. The average thresholds for bone conduction (BC) were 22.7±8.04 dB, and the bone-air interval (ABG) — 36.1±5.3 dB. According to CT of the temporal bones, all patients showed a bilateral and symmetrical decrease in the density of the auditory ossicles, and in 7 patients there were extensive areas of non-uniform decrease in the density of the bone labyrinth up to +500 — +1000 HU.21 patients underwent 23 operations: in 21 cases stapedoplasty with laser assistance and in 2 cases ossiculoplasty. Results. BC thresholds 6 months after surgery averaged 24.6±8.2 dB, and ABG — 12.1±2.9 dB. Closing of ABG ≤10 dB at spoken frequencies was detected in 30.5%, ABG ≤20 dB — in 95%. After 12 months or more after the operation, no change in the audiological parameters was noted. Conclusions. Stapes surgery for conductive and mixed hearing loss in OI patients is functionally effective. The best results are achieved after therapy with bisphosphonates with preparations of sodium fluoride, calcium and vitamin D, performing the operation when the density of demineralization zones reaches 1000 HU and using laser assistance. Taking into account the demineralization of the bone structures of the temporal bone, it is recommended to use autocartilaginous stirrup prostheses to restore sound conduction or to cover the attachment area of other prostheses with autologous tissues to prevent necrosis of the long stalk of the incus and stabilize long-term functional results.
- 28 December 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (6) , 5-14
Features and results of surgical rehabilitation of hearing loss in osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a form of congenital osteoporosis. Depending on the type of OI, patients experience various types of hearing loss. Depending on the type and degree of hearing loss, various methods of hearing rehabilitation are used in this category of patients. Objective. To evaluate the features and results of surgical rehabilitation of hearing loss in patients with osteogenesis imperfecta. Material and methods. During the period from 2009 to 2022, 2221 primary stapedoplasty was performed in the department, of which 23 (1.04%) in 21 patients were performed in patients with OI. There were 14 women and 7 men. According to TPA, bilateral hearing loss was detected in 19 patients and unilateral in 2. Conductive hearing loss was observed in 9 cases and mixed — in 14. The average thresholds for bone conduction (BC) were 22.7±8.04 dB, and the bone-air interval (ABG) — 36.1±5.3 dB. According to CT of the temporal bones, all patients showed a bilateral and symmetrical decrease in the density of the auditory ossicles, and in 7 patients there were extensive areas of non-uniform decrease in the density of the bone labyrinth up to +500 — +1000 HU.21 patients underwent 23 operations: in 21 cases stapedoplasty with laser assistance and in 2 cases ossiculoplasty. Results. BC thresholds 6 months after surgery averaged 24.6±8.2 dB, and ABG — 12.1±2.9 dB. Closing of ABG ≤10 dB at spoken frequencies was detected in 30.5%, ABG ≤20 dB — in 95%. After 12 months or more after the operation, no change in the audiological parameters was noted. Conclusions. Stapes surgery for conductive and mixed hearing loss in OI patients is functionally effective. The best results are achieved after therapy with bisphosphonates with preparations of sodium fluoride, calcium and vitamin D, performing the operation when the density of demineralization zones reaches 1000 HU and using laser assistance. Taking into account the demineralization of the bone structures of the temporal bone, it is recommended to use autocartilaginous stirrup prostheses to restore sound conduction or to cover the attachment area of other prostheses with autologous tissues to prevent necrosis of the long stalk of the incus and stabilize long-term functional results.
- 16 November 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (5) , 12-18
Clinical and radiological classification of otosclerosis
The article presents various classifications of forms of otosclerosis (OS), which change with the development of diagnostic methods. At the same time, according to the literature, a unified OS classification has not yet been adopted. All existing classifications are imperfect to some extent. The classification of clinical forms of OS according to TPA data makes it possible to determine the indications for surgical treatment and to suggest its possible effect, but not the localization of OS foci. X-ray classifications of localization of OS foci indicate their diversity, distribution, and do not always correlate with the type of hearing loss. At the same time, modern diagnostics of OS should be based on audiological data, localization of foci and their density according to the results of X-ray methods of examination. Based on the examination and treatment of 1532 patients with various forms of OS, a modern clinical and radiological classification of the disease is proposed, based precisely on these provisions. This classification, in our opinion, will improve the quality of diagnosis of various forms of OS, will allow to differentiate the tactics of treating patients with this disease to stabilize hearing loss, indications for surgical treatment, suggest its effectiveness with a reduction in the risk of surgical failures and possible further rehabilitation of the patient.
- 16 November 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (5) , 12-18
Clinical and radiological classification of otosclerosis
The article presents various classifications of forms of otosclerosis (OS), which change with the development of diagnostic methods. At the same time, according to the literature, a unified OS classification has not yet been adopted. All existing classifications are imperfect to some extent. The classification of clinical forms of OS according to TPA data makes it possible to determine the indications for surgical treatment and to suggest its possible effect, but not the localization of OS foci. X-ray classifications of localization of OS foci indicate their diversity, distribution, and do not always correlate with the type of hearing loss. At the same time, modern diagnostics of OS should be based on audiological data, localization of foci and their density according to the results of X-ray methods of examination. Based on the examination and treatment of 1532 patients with various forms of OS, a modern clinical and radiological classification of the disease is proposed, based precisely on these provisions. This classification, in our opinion, will improve the quality of diagnosis of various forms of OS, will allow to differentiate the tactics of treating patients with this disease to stabilize hearing loss, indications for surgical treatment, suggest its effectiveness with a reduction in the risk of surgical failures and possible further rehabilitation of the patient.
- 3 March 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (1) , 4-9
Features of innate immunity indicators in patients with recurrent exudative otitis media
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить уровень маркеров врожденного иммунитета в экссудате барабанной полости у пациентов с экссудативным средним отитом (ЭСО). МАТЕРИАЛ И МЕТОДЫ Обследованы 16 пациентов с рецидивирующим ЭСО. У 7 пациентов заболевание протекало на фоне хорошей проходимости слуховой трубы (1-я группа), а у 9 пациентов выявлена ее дисфункция (2-я группа). Изучена экспрессия генов врожденного иммунитета (TLR4, IL1B, TGFB, HBD1 и HBD2) в экссудате барабанной полости у больных ЭСО с нормальной проходимостью слуховой трубы и при ее дисфункции. РЕЗУЛЬТАТЫ Выявлены изменения показателей врожденного иммунного ответа, характерные для воспалительного процесса у больных с рецидивирующим ЭСО на фоне дисфункции слуховой трубы, по сравнению с показателями у пациентов без данной патологии. ЗАКЛЮЧЕНИЕ Полученные данные могут быть использованы для уточнения патогенеза среднего отита с дисфункцией слуховой трубы, разработки новых методов диагностики, профилактики и лечения этого заболевания.
- 3 March 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 88 (1) , 4-9
Features of innate immunity indicators in patients with recurrent exudative otitis media
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить уровень маркеров врожденного иммунитета в экссудате барабанной полости у пациентов с экссудативным средним отитом (ЭСО). МАТЕРИАЛ И МЕТОДЫ Обследованы 16 пациентов с рецидивирующим ЭСО. У 7 пациентов заболевание протекало на фоне хорошей проходимости слуховой трубы (1-я группа), а у 9 пациентов выявлена ее дисфункция (2-я группа). Изучена экспрессия генов врожденного иммунитета (TLR4, IL1B, TGFB, HBD1 и HBD2) в экссудате барабанной полости у больных ЭСО с нормальной проходимостью слуховой трубы и при ее дисфункции. РЕЗУЛЬТАТЫ Выявлены изменения показателей врожденного иммунного ответа, характерные для воспалительного процесса у больных с рецидивирующим ЭСО на фоне дисфункции слуховой трубы, по сравнению с показателями у пациентов без данной патологии. ЗАКЛЮЧЕНИЕ Полученные данные могут быть использованы для уточнения патогенеза среднего отита с дисфункцией слуховой трубы, разработки новых методов диагностики, профилактики и лечения этого заболевания.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (6)
Screening for laryngeal disease in patients with gastroesophageal reflux disease
ЦЕЛЬ ИССЛЕДОВАНИЯ Совершенствовать диагностику заболеваний гортани у пациентов с гастроэзофагеальной рефлюксной болезнью (ГЭРБ). МАТЕРИАЛ И МЕТОДЫ Обследован 171 пациент (89 (52%) мужчин и 82 (48%) женщины) с неэрозивной (39 (23%) человек) и эрозивной (132 (77%) человека) формами ГЭРБ. Ни один из пациентов не предъявлял активных жалоб на состояние гортани и глотки. Обследование включало анкетирование, осмотр оториноларингологом, видеоэндоларингоскопию. РЕЗУЛЬТАТЫ При анкетировании выявили наличие симптомов оториноларингологической патологии у 74% пациентов. При видеоларингоскопии у 55 (32%) пациентов патологии гортани не выявили, а у 116 (68%) пациентов выявлены признаки ГЭРБ-ассоциированного ларингита. Самой частой патологией была пахидермия межчерпаловидной области — у 89 человек, гранулему гортани выявили у 7 пациентов, лейкоплакию — у 2 пациентов, хронический отечно-полипозный ларингит — у 2 пациентов, доброкачественные образования гортани — у 9 пациентов. У пациентов с ГЭРБ (эрозивной и неэрозивной формами) в 44% случаев встречалось бессимптомное течение хронического ларингита, ассоциированного с данной патологией. У 52% пациентов диагностировалась пахидермия межчерпаловидной области, из них у каждого второго имелись выраженные гиперплазия и складчатость слизистой оболочки в межчерпаловидной области, которые необходимо дифференцировать с раком гортани (при этом пациенты должны находиться под динамическим наблюдением оториноларинголога). Другие предраковые образования гортани (гранулемы и лейкоплакия) встречались у 5% пациентов. Доброкачественные новообразования гортани (полипы и кисты) выявлены также в 5% случаев. ВЫВОДЫ Несмотря на высокую частоту выявления оториноларингологических заболеваний у обследованных пациентов с гастроэзофагеальной рефлюксной болезнью, никто из пациентов не предъявлял жалоб, связанных с патологией гортани, что свидетельствует о необходимости активного выявления данной патологии у этой категории больных путем анкетирования, опроса, а также осмотра врачом-оториноларингологом.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (6)
Screening for laryngeal disease in patients with gastroesophageal reflux disease
ЦЕЛЬ ИССЛЕДОВАНИЯ Совершенствовать диагностику заболеваний гортани у пациентов с гастроэзофагеальной рефлюксной болезнью (ГЭРБ). МАТЕРИАЛ И МЕТОДЫ Обследован 171 пациент (89 (52%) мужчин и 82 (48%) женщины) с неэрозивной (39 (23%) человек) и эрозивной (132 (77%) человека) формами ГЭРБ. Ни один из пациентов не предъявлял активных жалоб на состояние гортани и глотки. Обследование включало анкетирование, осмотр оториноларингологом, видеоэндоларингоскопию. РЕЗУЛЬТАТЫ При анкетировании выявили наличие симптомов оториноларингологической патологии у 74% пациентов. При видеоларингоскопии у 55 (32%) пациентов патологии гортани не выявили, а у 116 (68%) пациентов выявлены признаки ГЭРБ-ассоциированного ларингита. Самой частой патологией была пахидермия межчерпаловидной области — у 89 человек, гранулему гортани выявили у 7 пациентов, лейкоплакию — у 2 пациентов, хронический отечно-полипозный ларингит — у 2 пациентов, доброкачественные образования гортани — у 9 пациентов. У пациентов с ГЭРБ (эрозивной и неэрозивной формами) в 44% случаев встречалось бессимптомное течение хронического ларингита, ассоциированного с данной патологией. У 52% пациентов диагностировалась пахидермия межчерпаловидной области, из них у каждого второго имелись выраженные гиперплазия и складчатость слизистой оболочки в межчерпаловидной области, которые необходимо дифференцировать с раком гортани (при этом пациенты должны находиться под динамическим наблюдением оториноларинголога). Другие предраковые образования гортани (гранулемы и лейкоплакия) встречались у 5% пациентов. Доброкачественные новообразования гортани (полипы и кисты) выявлены также в 5% случаев. ВЫВОДЫ Несмотря на высокую частоту выявления оториноларингологических заболеваний у обследованных пациентов с гастроэзофагеальной рефлюксной болезнью, никто из пациентов не предъявлял жалоб, связанных с патологией гортани, что свидетельствует о необходимости активного выявления данной патологии у этой категории больных путем анкетирования, опроса, а также осмотра врачом-оториноларингологом.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (6)
Treatment of laryngeal pathology associated with gastroesophageal reflux disease
ЦЕЛЬ ИССЛЕДОВАНИЯ Повысить эффективность лечения патологии гортани, ассоциированной с гастроэзофагеальной рефлюксной болезнью (ГЭРБ), определить показания к назначению противовоспалительной терапии этим пациентам. МАТЕРИАЛ И МЕТОДЫ Проведено обследование и лечение 120 пациентов, из них 58 мужчин и 62 женщин, в возрасте от 30 до 82 лет с ГЭРБ-ассоциированной патологией гортани. Сформированы три группы пациентов, сопоставимые по возрасту и полу, в соответствии с типом пахидермии межчерпаловидной области; 1-й тип (40 больных) — пахидермия не выходит за пределы середины черпаловидного хряща (по Г.Ф. Иванченко), менее 3 мм, без признаков перифокального воспаления; 2-й тип (40 больных) — пахидермия больших размеров, выходящая за пределы середины черпаловидного хряща с распространением на всю межчерпаловидную область (по Г.Ф. Иванченко), часто в сочетании с гиперкератозом или дисплазией эпителия; 3-й тип (30 больных) — пахидермия больших размеров в сочетании с выраженным перифокальным воспалением. Все пациенты получали антирефлюксную терапию. Каждая группа разделена на две подгруппы: пациенты, которые не получали противовоспалительную терапию, и пациенты, получавшие противовоспалительную терапию, основу которой составили ингаляции дегазированной щелочной минеральной водой, а также по показаниям ацетилцистеин, бензилдиметиламмония хлорид 0,01% или гидроксиметилхиноксалиндиоксид, при выраженном отеке слизистой оболочки — будесонид. Все пациенты заполняли опросник «Шкала рефлюксных симптомов» до и после лечения. РЕЗУЛЬТАТЫ У пациентов 2-й группы (при пахидермии 2-го типа) эффективность противовоспалительной терапии составила 75%. Из 20 пациентов этой группы после ингаляционной терапии у 4 пациентов пахидермия межчерпаловидной области исчезла, у 11 пациентов визуализировался 1-й тип пахидермии, у 5 (25%) пациентов выраженная динамика не отмечена. У пациентов 3-й группы (с пахидермией 3-го типа) эффективность ингаляционного лечения составила 100%, из 15 пациентов после ингаляционной терапии 2-й тип пахидермии диагностирован у 8 пациентов, 1-й тип пахидермии — у 7 пациентов. У 4 пациентов комплексная терапия привела к полному исчезновению рефлюкс-ассоциированных гранулем гортани без хирургического лечения. Эффективность ингаляционной терапии в отношении жалоб пациентов через месяц составила 87%, тогда как эффективность лечения пациентов без ингаляций — 45%. ВЫВОДЫ Показаниями к назначению ингаляционной противовоспалительной терапии у пациентов с рефлюкс-ассоциированной патологией гортани являются наличие жалоб на охриплость, сухость, першение, ком в горле и хронический кашель, эндоларингоскопические признаки обострения хронического воспаления слизистой оболочки задних отделов гортани.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 87 (6)
Treatment of laryngeal pathology associated with gastroesophageal reflux disease
ЦЕЛЬ ИССЛЕДОВАНИЯ Повысить эффективность лечения патологии гортани, ассоциированной с гастроэзофагеальной рефлюксной болезнью (ГЭРБ), определить показания к назначению противовоспалительной терапии этим пациентам. МАТЕРИАЛ И МЕТОДЫ Проведено обследование и лечение 120 пациентов, из них 58 мужчин и 62 женщин, в возрасте от 30 до 82 лет с ГЭРБ-ассоциированной патологией гортани. Сформированы три группы пациентов, сопоставимые по возрасту и полу, в соответствии с типом пахидермии межчерпаловидной области; 1-й тип (40 больных) — пахидермия не выходит за пределы середины черпаловидного хряща (по Г.Ф. Иванченко), менее 3 мм, без признаков перифокального воспаления; 2-й тип (40 больных) — пахидермия больших размеров, выходящая за пределы середины черпаловидного хряща с распространением на всю межчерпаловидную область (по Г.Ф. Иванченко), часто в сочетании с гиперкератозом или дисплазией эпителия; 3-й тип (30 больных) — пахидермия больших размеров в сочетании с выраженным перифокальным воспалением. Все пациенты получали антирефлюксную терапию. Каждая группа разделена на две подгруппы: пациенты, которые не получали противовоспалительную терапию, и пациенты, получавшие противовоспалительную терапию, основу которой составили ингаляции дегазированной щелочной минеральной водой, а также по показаниям ацетилцистеин, бензилдиметиламмония хлорид 0,01% или гидроксиметилхиноксалиндиоксид, при выраженном отеке слизистой оболочки — будесонид. Все пациенты заполняли опросник «Шкала рефлюксных симптомов» до и после лечения. РЕЗУЛЬТАТЫ У пациентов 2-й группы (при пахидермии 2-го типа) эффективность противовоспалительной терапии составила 75%. Из 20 пациентов этой группы после ингаляционной терапии у 4 пациентов пахидермия межчерпаловидной области исчезла, у 11 пациентов визуализировался 1-й тип пахидермии, у 5 (25%) пациентов выраженная динамика не отмечена. У пациентов 3-й группы (с пахидермией 3-го типа) эффективность ингаляционного лечения составила 100%, из 15 пациентов после ингаляционной терапии 2-й тип пахидермии диагностирован у 8 пациентов, 1-й тип пахидермии — у 7 пациентов. У 4 пациентов комплексная терапия привела к полному исчезновению рефлюкс-ассоциированных гранулем гортани без хирургического лечения. Эффективность ингаляционной терапии в отношении жалоб пациентов через месяц составила 87%, тогда как эффективность лечения пациентов без ингаляций — 45%. ВЫВОДЫ Показаниями к назначению ингаляционной противовоспалительной терапии у пациентов с рефлюкс-ассоциированной патологией гортани являются наличие жалоб на охриплость, сухость, першение, ком в горле и хронический кашель, эндоларингоскопические признаки обострения хронического воспаления слизистой оболочки задних отделов гортани.